<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01360060</url>
  </required_header>
  <id_info>
    <org_study_id>Mg_section</org_study_id>
    <nct_id>NCT01360060</nct_id>
  </id_info>
  <brief_title>Analgesia After Cesarean Section</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <brief_summary>
    <textblock>
      Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia
      in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an
      effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of
      magnesium in parturients undergoing Cesarean section.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of numeric rating scale (NRS) of postoperative pain during postoperative period</measure>
    <time_frame>postoperative 1, 2, 3, and 4 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of stopping of intravenous PCA during postoperative 4 days</measure>
    <time_frame>during postoperative 4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum magnesium level of group P</measure>
    <time_frame>preoperative 1 h and postoperative 1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">503</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Group N</arm_group_label>
    <description>parturients who had undergone Cesarean section under the diagnosis of non-preeclampsia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <description>parturients who had undergone Cesarean section under the diagnosis of preeclampsia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulphate</intervention_name>
    <description>Magnesium sulphate was infused for the management of preeclampsia at perioperative period.</description>
    <arm_group_label>Group P</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        medical record review
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  parturients undergoing Cesarean section
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul national university bundang hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2011</study_first_submitted>
  <study_first_submitted_qc>May 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2011</study_first_posted>
  <last_update_submitted>May 24, 2011</last_update_submitted>
  <last_update_submitted_qc>May 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>Hyoseok, Na/professor</name_title>
    <organization>Seoul National University Bundang Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

